Michael Quirmbach
Michael Quirmbach is the CEO of Corden Pharma, a contract manufacturer based in Basel, Switzerland. He has been navigating the challenges posed by increasing demand from clients for U.S.-based production capabilities, as many pharmaceutical companies seek to mitigate risks associated with tariffs. Quirmbach is also focused on expanding Corden's manufacturing capacity in Colorado to meet the growing demand for specific drug preparations.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.08% | +0% | 8,654,622 | 6,913 | $700,000 | 559$ |
| Totals | 1 | 8,654,622 | 6,913 | $700,000 | 559$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Michael Quirmbach is the CEO of Corden Pharma, who is receiving requests from clients to produce in the USA.
5